Immunovant IMVT
NASDAQ IMVT
$35.71 +0.56 (+1.59%)
At close: Nov 10, 2026 · 4:00 PM EST

Immunovant (IMVT) Interest Coverage Ratio (2019)

Updated

Immunovant's (IMVT) Interest Coverage Ratio stood at -105.07 in FY2020 (year ended Mar 31, 2020).

Analysis

Immunovant (IMVT) Interest Coverage Ratio (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Immunovant 7.38 Bn 3.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -28.78
Sep 30, 2019 -1.69
API Access

Immunovant Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=IMVT&period=max&api_key=YOUR_API_KEY